Keros Therapeutics KROS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 20.36 | 117.20 | 9.62 | -0.38 | -29,270 | -23 |
| 2025Q3 | 15.82 | 176.75 | 34.23 | -0.18 | -15,384 | -7 |
| 2025Q2 | 13.35 | 120.96 | 128.73 | -0.76 | -39,817 | -31 |
| 2025Q1 | 10.19 | 95.93 | 3.62 | 152,040 | 148 | |
| 2024Q4 | 15.83 | 116.46 | -1.12 | -53,254 | -46 | |
| 2024Q3 | 58.07 | 110.77 | -1.42 | -58,657 | -53 | |
| 2024Q2 | 45.70 | 111.45 | -1.25 | -50,439 | -45 | |
| 2024Q1 | 66.20 | 112.45 | -1.21 | -48,483 | -43 | |
| 2023Q4 | 39.76 | 115.44 | -1.34 | -46,455 | -40 | |
| 2023Q3 | 31.88 | 109.74 | -1.33 | -43,280 | -39 | |
| 2023Q2 | 40.18 | 110.22 | -1.27 | -41,337 | -38 | |
| 2023Q1 | 42.70 | 108.56 | -1.26 | -38,869 | -36 | |
| 2022Q4 | 48.02 | 107.54 | -1.10 | -31,960 | -30 | |
| 2022Q3 | 37.62 | 119.00 | -0.91 | -27,976 | -24 | |
| 2022Q2 | 27.63 | 112.70 | -1.13 | -30,728 | -27 | |
| 2022Q1 | 54.38 | 99.76 | -1.01 | -24,126 | -24 | |
| 2021Q4 | 58.51 | 98.50 | -0.30 | -4,866 | -7 | |
| 2021Q3 | 39.56 | 99.33 | -0.87 | -20,197 | -20 | |
| 2021Q2 | 42.47 | 99.49 | -0.67 | -15,541 | -16 | |
| 2021Q1 | 61.55 | 99.59 | -0.68 | -15,769 | -16 |